Biotech · Private company
Pathalys Pharma
Track this companyFree. Adds Pathalys Pharma to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Open-Label Extension PLS240Phase 3 · Secondary HyperparathyroidismClinicalTrials.gov · fetched Nov 12, 2026
- PLS240Phase 3 · Chronic Kidney Disease (CKD)ClinicalTrials.gov · fetched Nov 12, 2026
- PLS240Phase 3 · Secondary HyperparathyroidismClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of PLS240 in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on HemodialysisPHASE3 · NOT_YET_RECRUITING · started Oct 30, 2026ClinicalTrials.gov NCT07890584 · fetched Nov 12, 2026
- Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2PHASE3 · COMPLETED · started May 15, 2023ClinicalTrials.gov NCT05836220 · fetched Nov 12, 2026
- Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1PHASE3 · COMPLETED · started Apr 28, 2023ClinicalTrials.gov NCT05832931 · fetched Nov 12, 2026